Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
EYPT - LONG-TERM DEBT
Long-term Debt EYPT - EyePoint Pharmaceuticals, Inc.
4.91 M
LAST VALUE
-64.27%
2 YEAR CAGR
-22.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR